ENOV News and Press, Enovis Corporation From 02/22/23

Enovis Corporation ( NYSE: ENOV ) is scheduled to announce Q4 earnings results on Thursday, February 23rd, before market open. The consensus EPS Estimate is $0.66 (+11.9% Y/Y) and the consensus Revenue Estimate is $415.79M. Over the last 2 years, ENOV has beaten EPS estimate...

Summary Smith & Nephew plc's fourth quarter results were mixed; Ortho is still lagging its rivals, but Sports Medicine & ENT and Advanced Wound Care outperformed. The company has the technology to be more competitive in ortho and gain share in major joints and extremities, but w...

Wilmington, DE, Feb. 10, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its fourth quarter and full year 2022 financial results on Thursd...

Wilmington, DE, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Today, Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced it will showcase its growing Foot & Ankle offerings at the 2023 American College of Foot and Ankle Surgeons (ACFAS) Scientific Conference in Los...

Summary ESAB Corporation has had a lumpy operating history, but the overall picture for the business in recent years has been positive. This year, the firm has faced some pressure on its bottom line, but sales do continue to climb nicely. Add in how shares are priced, and the compan...

The following slide deck was published by Enovis Corporation in conjunction with this event. For further details see: Enovis (ENOV) Presents At 41st Annual Healthcare Conference - Slideshow

Wilmington, DE, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Today, Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced the launch of the DynaClip Delta™ and DynaClip Quattro™ bone staples, the latest additions to the Company’s growing foot and an...

Wilmington, DE, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will meet with investors at the 41 st Annual J.P. Morgan Healthcare Conference with a presentation sched...

Summary Jeff Smith’s 13F portfolio value decreased from $5.50B to $4.55B this quarter. Starboard Value added Wix.com while decreasing ON Semiconductor and Huntsman Corp. The largest three individual stock positions are GoDaddy, Aecom, and Humana. They add up to ~34% of the po...

Wilmington, DE, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced that the U.S. Food and Drug Administration (FDA) has approved the STAR Patient Specific Instrumentation (STAR PSI System) for use with the Company...